A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center found that patients with evidence of residual cancer in their blood after surgery to remove the cancer, may benefit from adding of celecoxib, to post surgery treatment.
Hospices can’t handle the growing number of patients who need wound care
A few years ago, I worked with a patient close to 100 years old. She had diabetes for most of her adult life, which affected
November 24, 2023